Treatment of chronic hepatitis C in children: Is it necessary and, if so, in whom?

Journal of Hepatology

Volumn 52, Issue 4, 2010, Pages 472-474

  Alisi, Anna ^a   Comparcola, Donatella ^a   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANXIETY DISORDER; CHILDHOOD DISEASE; CLINICAL TRIAL; DEPRESSION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSOMNIA; IRRITABILITY; LIVER BIOPSY; MONOTHERAPY; NEUTROPENIA; NEWBORN SCREENING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION; VIRUS LOAD; VIRUS TRANSMISSION; WEIGHT REDUCTION;

ANTIVIRAL AGENTS; CHILD; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; POLYETHYLENE GLYCOLS;

EID: 77949775333     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.12.018     Document Type: Editorial

References (20)

1. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5 (2005) 558-567
2. Hsu E.K., and Murray K.F. Hepatitis B and C in children. Nat Clin Pract Gastroenterol Hepatol 5 (2008) 311-320
3. Yeung LT, Roberts EA. Current issues in the management of paediatric viral hepatitis. Liver Int 2009 [Epub ahead of print].
4. Ghany M.G., Strader D.B., Thomas D.L., and Seeff L.B. American association for the study of liver diseases. diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49 (2009) 1335-1374
5. Davison S.M., Mieli-Vergani G., Sira J., and Kelly D.A. Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91 (2006) 781-785
6. Lai M.E., DeVirgilis S., Argiolu F., Farci P., Mazzoleni A.P., Lisci V., et al. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of post transfusion hepatitis among thalassemic children: comparison between first and second generation assay. J Ped Gastroenterol Nutr 16 (1993) 458-464
7. Badizagen K., Jonas M.M., Ott M.J., Nelson S.P., and Perez-Atayde A.R. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 28 (1998) 1416-1423
8. Cesaro S., Petris M.G., Rossetti F., Cusinato R., Pipan C., Guido M., et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90 (1997) 1315-1320
9. Locasciulli A., Testa M., Pontisso P., Benvegnu L., Fraschini D., Corbetta A., et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 90 (1997) 4628-4633
10. Strickland D.K., Reily C.A., Patrick C.C., Jones-Wallace D., Boyett J.M., Waters B., et al. Hepatitis C infection among survivors of childhood cancer. Blood 95 (2000) 3065-3070
11. Castellino S., Lensing S., Reily C., Rai S.N., Davila R., Hayden R.T., et al. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 103 (2004) 2460-2466
12. Benhamou Y., Bochet M., DiMartino V., Charlotte F., Azria F., Coutellier A., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30 (1999) 1054-1058
13. Jacobson K.R., Murray K., Zellos A., and Schwarz K.B. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 34 (2002) 52-58
14. Wirth S., Pieper-Boustani H., Lang T., Ballauff A., Kullmer U., Gerner P., et al. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 41 (2005) 1013-1018
15. Jara P., Hierro L., de la Vega A., Diaz C., Camarena C., Frauca E., et al. Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. Pediatr Infect Dis J 27 (2008) 142-148
16. Wirth S., Ribes-Koninckx C., Calzado M.A., Bortolotti F., Zancan L., Jara P., et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 52 (2010) 501-507
17. Nydegger A., Srivastava A., Wake M., Smith A.L., and Hardikar W. Health-related quality of life in children with hepatitis C acquired in the first year of life. J Gastroenterol Hepatol 23 (2008) 226-230
18. Nobili V., Parkes J., Bottazzo G., Marcellini M., Cross R., Newman D., et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 136 (2009) 160-167
19. Nobili V., Vizzutti F., Arena U., Abraldes J.G., Marra F., Pietrobattista A., et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48 (2008) 442-448
20. Schwarz K.B., Gonzalez-Peralta R.P., Murray K.F., Molleston J.P., Haber B., Jonas M.M., et al. Peginterferon with or without ribavirin for chronic hepatitis C in children and adolescents: final results of the Peds-C trial. Hepatology 48 (2008) 418A [Abst. 242]